Amber

Moderna, Inc. is a Cambridge, Massachusetts-based biotechnology company that is focused on drug discovery and drug development based on messenger RNA (mRNA). The company creates synthetic mRNA that can be injected into patients to help them create their own therapies.

Click to see more
Moderna, Inc. News
MRNA Stock Lost 6%, Moderna Booster Effective against COVID-19 Variants of Brazil and South Africa
By May 6th, 2021
Business News, Market News, News, Stocks, Wall Street MRNA Stock Lost 6%, Moderna Booster Effective against COVID-19 Variants of Brazil and South Africa
By May 6th, 2021

Moderna’s booster shots combined with new COVID-19 vaccine variant is capable of creating more antibodies especially against the Brazilian and South African variant. Moderna will soon publish tests of its trials online. Besides, all eyes are on its earnings reports releasing later today.

EarnBet